- All sections
- C - Chemistry; metallurgy
- C07D - Heterocyclic compounds
- C07D 207/12 - Oxygen or sulfur atoms
Patent holdings for IPC class C07D 207/12
Total number of patents in this class: 725
10-year publication summary
|
52
|
46
|
43
|
67
|
45
|
53
|
64
|
46
|
35
|
13
|
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Sanofi | 3836 |
23 |
| Bristol-myers Squibb Company | 5080 |
21 |
| Journey Medical Corporation | 93 |
19 |
| Takeda Pharmaceutical Company Limited | 2961 |
18 |
| Novartis AG | 11238 |
17 |
| F. Hoffmann-La Roche AG | 7958 |
12 |
| Boehringer Ingelheim International GmbH | 4629 |
10 |
| Bodor Laboratories, Inc. | 59 |
10 |
| Merck Sharp & Dohme LLC | 3689 |
8 |
| AstraZeneca AB | 3042 |
7 |
| Astellas Pharma Inc. | 1145 |
7 |
| Chiesi Farmaceutici S.p.A. | 940 |
7 |
| Integrative Research Laboratories Sweden AB | 25 |
7 |
| Correvio International Sàrl | 25 |
7 |
| Hoffmann-La Roche Inc. | 3060 |
6 |
| Cayman Chemical Company, Incorporated | 72 |
6 |
| Correvio Canada Corp. | 21 |
6 |
| Centre National de La Recherche Scientifique | 9632 |
5 |
| Kaneka Corporation | 4445 |
5 |
| Alnylam Pharmaceuticals, Inc. | 1066 |
5 |
| Other owners | 519 |